0
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Editor's Correspondence |  March 24, 2008
Risks of Combining Immunosuppressive and Biological Treatments in Inflammatory Bowel Disease
Xavier Roblin, MD; Jean Marc Phelip, MD, PhD
Arch Intern Med. 2008;168(6):667. doi:10.1001/archinte.168.6.667.
Editor's Correspondence |  March 24, 2008
Risks of Combining Immunosuppressive and Biological Treatments in Inflammatory Bowel Disease—Reply
Dario Sorrentino, MD; Giovanni Terrosu, MD; Claudio Avellini, MD
Arch Intern Med. 2008;168(6):667-668. doi:10.1001/archinte.168.6.667-a.
Research Letters |  September 10, 2007 FREE
Infliximab With Low-Dose Methotrexate for Prevention of Postsurgical Recurrence of Ileocolonic Crohn Disease
Dario Sorrentino, MD; Giovanni Terrosu, MD; Claudio Avellini, MD; et al.
Arch Intern Med. 2007;167(16):1804-1807. doi:10.1001/archinte.167.16.1804.
Editor's Correspondence |  November 08, 2004
Antisperm Antibodies in Inflammatory Bowel Disease
Marco Rossato, MD, PhD; Carlo Foresta, MD
Arch Intern Med. 2004;164(20):2281-2283. doi:10.1001/archinte.164.20.2283.
Editor's Correspondence |  June 10, 2002
Hepatobiliary Alterations in Patients With Inflammatory Bowel Disease
L. Caserta, MD; G. Riegler, MD
Arch Intern Med. 2002;162(11):1310-1311. doi:.
Editor's Correspondence |  June 10, 2002
Hepatobiliary Alterations in Patients With Inflammatory Bowel Disease—Reply
Mirella Fraquelli, MD, PhD; Alice Colucci, MD; Silvia Paggi, MD; et al.
Arch Intern Med. 2002;162(11):1310-1311. doi:.
Original Investigation |  October 08, 2001 FREE
Gallstone Disease and Related Risk Factors in Patients With Crohn Disease:  Analysis of 330 Consecutive Cases
Mirella Fraquelli, MD, PhD; Alessandra Losco, MD; Stefania Visentin, MD; et al.
Arch Intern Med. 2001;161(18):2201-2204. doi:10.1001/archinte.161.18.2201.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Surgery
Invited Critique  |  May 01, 2013
The Out-of-Circuit Rectum in Ulcerative Colitis: The Bumpy Road Less Traveled:  Comment on “ Fate of Rectal Stump After Subtotal Colectomy for Ulcerative Colitis in the Era of Ileal Pouch–Anal Anastomosis”
Walter E. Longo, MD
JAMA Surgery
Paper  |  May 01, 2013
Fate of the Rectal Stump After Subtotal Colectomy for Ulcerative Colitis in the Era of Ileal Pouch–Anal Anastomosis
Semeret Munie, MD; Neil Hyman, MD; Turner Osler, MD
JAMA Dermatology
Evidence-Based Dermatology: Study  |  Feb 2013
Isotretinoin and Risk for Inflammatory Bowel Disease:  A Nested Case-Control Study and Meta-analysis of Published and Unpublished Data
Mahyar Etminan, PharmD, MSc; Steven T. Bird, PharmD, MS; Joseph A. Delaney, PhD; et al.
JAMA Dermatology
Editorial  |  Feb 2013
The Weight of Evidence on the Association of Isotretinoin Use and the Development of Inflammatory Bowel Disease
Cătălin Mihai Popescu, MD, PhD; Michael Bigby, MD
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems